Homeostatic Disinhibition in the aging brain and alzheimer's disease

Marc Gleichmann, Vivian W. Chow, Mark P. Mattson

Research output: Contribution to journalArticle

Abstract

In this article, we propose that impaired efficiency of glutamatergic synaptic transmission and a compensatory reduction in inhibitory neurotransmission, a process called homeostatic dishinhibition, occurs in the aging brain and more dramatically in Alzheimer's disease (AD). Homeostatic disinhibition may help understand certain features of the aging brain and AD, including: 1) the increased risk for epileptic seizures, especially in the early phase of the disease; 2) the reduced ability to generate γ-oscillations; and 3) the increase in neuronal activity as measured by functional MRI. Homeostatic disinhibition may be the major mechanism that activates cognitive reserve. Modulating neuronal activity may therefore be a viable therapeutic strategy in AD that can complement existing anti-amyloid strategies. Specifically, enhancing endogenous glutamatergic synaptic transmission through increased co-agonist signaling or through positive allosteric modulation of metabotropic glutamatergic receptors appears as an attractive strategy. Alternatively, further reduction of GABAergic signaling may work as well, although care has to be taken to prevent epileptic seizures.

Original languageEnglish (US)
Pages (from-to)15-24
Number of pages10
JournalJournal of Alzheimer's Disease
Volume24
Issue number1
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Brain Diseases
Synaptic Transmission
Alzheimer Disease
Epilepsy
Cognitive Reserve
Aptitude
Amyloid
Magnetic Resonance Imaging
Efficiency
Brain
Therapeutics

Keywords

  • Alzheimer's disease
  • cognitive reserve
  • disinhibition
  • GABA
  • interneuron
  • neuronal activity

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Homeostatic Disinhibition in the aging brain and alzheimer's disease. / Gleichmann, Marc; Chow, Vivian W.; Mattson, Mark P.

In: Journal of Alzheimer's Disease, Vol. 24, No. 1, 2011, p. 15-24.

Research output: Contribution to journalArticle

Gleichmann, Marc ; Chow, Vivian W. ; Mattson, Mark P. / Homeostatic Disinhibition in the aging brain and alzheimer's disease. In: Journal of Alzheimer's Disease. 2011 ; Vol. 24, No. 1. pp. 15-24.
@article{ee1bc8d8704b4a10824bfc2aac4b4230,
title = "Homeostatic Disinhibition in the aging brain and alzheimer's disease",
abstract = "In this article, we propose that impaired efficiency of glutamatergic synaptic transmission and a compensatory reduction in inhibitory neurotransmission, a process called homeostatic dishinhibition, occurs in the aging brain and more dramatically in Alzheimer's disease (AD). Homeostatic disinhibition may help understand certain features of the aging brain and AD, including: 1) the increased risk for epileptic seizures, especially in the early phase of the disease; 2) the reduced ability to generate γ-oscillations; and 3) the increase in neuronal activity as measured by functional MRI. Homeostatic disinhibition may be the major mechanism that activates cognitive reserve. Modulating neuronal activity may therefore be a viable therapeutic strategy in AD that can complement existing anti-amyloid strategies. Specifically, enhancing endogenous glutamatergic synaptic transmission through increased co-agonist signaling or through positive allosteric modulation of metabotropic glutamatergic receptors appears as an attractive strategy. Alternatively, further reduction of GABAergic signaling may work as well, although care has to be taken to prevent epileptic seizures.",
keywords = "Alzheimer's disease, cognitive reserve, disinhibition, GABA, interneuron, neuronal activity",
author = "Marc Gleichmann and Chow, {Vivian W.} and Mattson, {Mark P.}",
year = "2011",
doi = "10.3233/JAD-2010-101674",
language = "English (US)",
volume = "24",
pages = "15--24",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Homeostatic Disinhibition in the aging brain and alzheimer's disease

AU - Gleichmann, Marc

AU - Chow, Vivian W.

AU - Mattson, Mark P.

PY - 2011

Y1 - 2011

N2 - In this article, we propose that impaired efficiency of glutamatergic synaptic transmission and a compensatory reduction in inhibitory neurotransmission, a process called homeostatic dishinhibition, occurs in the aging brain and more dramatically in Alzheimer's disease (AD). Homeostatic disinhibition may help understand certain features of the aging brain and AD, including: 1) the increased risk for epileptic seizures, especially in the early phase of the disease; 2) the reduced ability to generate γ-oscillations; and 3) the increase in neuronal activity as measured by functional MRI. Homeostatic disinhibition may be the major mechanism that activates cognitive reserve. Modulating neuronal activity may therefore be a viable therapeutic strategy in AD that can complement existing anti-amyloid strategies. Specifically, enhancing endogenous glutamatergic synaptic transmission through increased co-agonist signaling or through positive allosteric modulation of metabotropic glutamatergic receptors appears as an attractive strategy. Alternatively, further reduction of GABAergic signaling may work as well, although care has to be taken to prevent epileptic seizures.

AB - In this article, we propose that impaired efficiency of glutamatergic synaptic transmission and a compensatory reduction in inhibitory neurotransmission, a process called homeostatic dishinhibition, occurs in the aging brain and more dramatically in Alzheimer's disease (AD). Homeostatic disinhibition may help understand certain features of the aging brain and AD, including: 1) the increased risk for epileptic seizures, especially in the early phase of the disease; 2) the reduced ability to generate γ-oscillations; and 3) the increase in neuronal activity as measured by functional MRI. Homeostatic disinhibition may be the major mechanism that activates cognitive reserve. Modulating neuronal activity may therefore be a viable therapeutic strategy in AD that can complement existing anti-amyloid strategies. Specifically, enhancing endogenous glutamatergic synaptic transmission through increased co-agonist signaling or through positive allosteric modulation of metabotropic glutamatergic receptors appears as an attractive strategy. Alternatively, further reduction of GABAergic signaling may work as well, although care has to be taken to prevent epileptic seizures.

KW - Alzheimer's disease

KW - cognitive reserve

KW - disinhibition

KW - GABA

KW - interneuron

KW - neuronal activity

UR - http://www.scopus.com/inward/record.url?scp=79955662632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955662632&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-101674

DO - 10.3233/JAD-2010-101674

M3 - Article

C2 - 21187584

AN - SCOPUS:79955662632

VL - 24

SP - 15

EP - 24

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -